| BioPharmaceutical Market Industry |
|---|
| More Pages: Page: (1) |
| OTCBB:DOVPW | DOV Pharmaceutical, Inc. Warrants 6/2/2009 | | | DOV Pharmaceutical is a biopharmaceutical company focused on the discovery, in-licensing, development and commercialization of novel drug candidates for central nervous system, or CNS, and other disorders, including cardiovascular, that involve alterations in neuronal processing. | | | Market Cap | Day's Volume | Last Trade | Change | | | - | 0 | $0.0001 | 0.0% | | |
| OTC PK:HCCF | Hee Corporation Common Stock (Delaware) | | | The Hee Corp. serves as a provider of corporate vehicles for the nutraceutical cure for Type II Diabetes. This nutraceutical was developed and tested in India. Hee Corp. has the worldwide rights, except in India, and is currently bringing it to the marketplace. | | | Market Cap | Day's Volume | Last Trade | Change | | | - | 0 | $0.0002 | 0.0% | | |
| OTCBB:RXHN | Rexahn Pharmaceuticals, Inc. | | | Rexahn Pharmaceuticals, Inc. is a biopharmaceutical company involved in the discovery, developing, and commercialization of innovative products for the treatment of cancer and disorders of the central nervous system. | | | Market Cap | Day's Volume | Last Trade | Change | | | - | 0 | $3.20 | 0.0% | | |
| NASDAQ:XNPT | XENOPORT | | | XenoPort is a biopharmaceutical company that develops a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs. At Dec 31 2006, Co.'s proprietary product candidates included: XP13512 , a Transported Prodrug of gabapentin which is designed for the treatment of the restless leg syndrome; XP13512 , for Neuropathic Pain, including post-herpetic neuralgia; XP19986 , a Transported Prodrug of R-baclofen for the treatment of gastroesophageal reflux disease and Spasticity; XP21279 for the treatment of Parkinson's Disease; and XP20925 for Migraine and Chemotherapy-Induced Nausea and Vomiting. | | | Market Cap | Day's Volume | Last Trade | Change | | | - | 243,280 | $6.25 | -0.636% | | |
| More Pages: Page: (1) |
|
| More |
|---|
Investing by Industry or Market Sector employs non-emotional, numbers driven, value-based industry, sector, and country rotation techniques, that, unlike conventional stock picking methods, focuses instead on identifying and capitalizing on theme movements in the well identified industries & market sectors.
Primarily, this active-asset methodology recognizes that advances in financial markets are defined by "themes", or led by asset classes, industries, and countries, with each advance distinguished by specific sector-driven themes. Employing a disciplined research and valuation process these "themes" are identified so that Portfolio's can be created and/or adjusted toward the most attractive sectors.
|
|
